Palliative Care

Clinical trials for end of life care and symptom control. This includes pain management, breathlessness and loss of appetite.

f you would like to be considered for a clinical trial you will require a referral from your current treating team. Visit the Joining a Clinical Trial page for referral information. 

For more information on clinical trials, get in contact with our cancer clinical trials enquiry coordinator.

Clinical Trials Enquiry Coordinator

Business hours, Mon to Friday between 9am - 2pm
Email [email protected]
Phone (03) 8559 7456

Open and Recruiting Clinical Trials

A clinical trial to test if Oxycodone/Naloxone prolonged release is better than oxycodone prolonged release tablets in patients with advanced cancer

Cancer Type

Palliative Care

Status

Open and recruiting

Phase

Four: A phase four clinical trial monitors safety in real world, assessing new products with products that are already available. This is typically the safest type of clinical trial because the treatment has already been studied a lot and might have already been used in many people. Phase four studies look at safety over time. These studies may also look at other aspects of the treatment, cost of the product and patients quality of life.

Brief summary

A clinical trial to find out if cancer patients with pain have their pain controlled better with oxycodone/naloxone prolonged release compared with cancer patients taking oxycodone prolonged release over a 5-week period.

Who can participate

Patients who:

  • Have a solid cancer that has spread to other parts of the body or a haematological malignancy
  • Have moderate to severe cancer-related pain

Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.

A clinical trial to test whether oral Melatonin can prevent delirium in hospitals in patients with advanced cancer

Cancer Type

Palliative Care

Status

Open and recruiting

Phase

Three: A phase three clinical trial follows a phase two, in a larger group of patients with specific cancer types. The aim of a phase three is to compare the new treatment to what is available for that cancer type.

Brief summary

The research project is testing a new oral treatment for delirium, which is a condition that can occur when someone is medically unwell and admitted to hospital. Delirium is particularly common for people with cancer. The new treatment is called melatonin.

Who can participate

Patients who:

  • Have Lung cancer
  • Are able to complete questions without assistance

Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.